Home >
Groups > Leader (Specially appointed researchers)
Groups
Specially appointed researchers group
Group leader
Shin-ichiro Hayashi, M.D., Ph.D.
Current Position
- Physician and Chaiman, Hayashi Medical Clinic
- Associate Professor (Specially Appointed), Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University
- Visiting Researcher, Division of Arrhythmia, Department of Cardiovascular Medicine, National Cardiovascular Research Center
- Visiting Researcher, Department of Aging Neurobiology, Center for Development of Advanced Medicine for Dementia. Molecular Basis Research, National Center for Geriatrics and Gerontology
Academic Appointments
- 2000-2002
-
Research Associate in Medicine, Division of Cardiovascular Medicine,
Stanford University School of Medicine, Stanford, CA, USA
- 2002-2004
-
Associate in Medicine, Division of Gene Therapy, Osaka University Graduate School of Medicine, Osaka, Japan
- 2004-2005
-
Assistant Professor of Medicine, Tokyo University Graduate School of Medicine, Tokyo, Japan
- 2005-2011
-
Assistant Professor of Medicine, Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu, Japan
- 2011-2019
-
Senior Researcher of Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Research Center, Osaka, Japan
- 2019- present
-
Associate Professor of Medicine, Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Osaka, Japan
Education
- 1994
-
Doctor in Medicine (M.D.), Faculty of Medicine, The University of Tokushima
- 1998
-
Doctor in Medicine (Ph.D.), Graduate School of Medicine, Osaka University
Professional Affiliation
American Heart Association (Fellow)
European Society of Cardiology (Fellow)
Japanese Circulation Society (Fellow/ Councilor)
The Japanese Society of Hypertension (Member/ Councilor)
Japanese College of Angiology (Member/ Councilor)
Japan Sports Association (Sports Doctor)
Research Theme
To elucidate the links between cardiovascular disease, lifestyle-related diseases, and ageing, and to use these findings to advance the development of molecular therapeutics.
[Specially appointed researchers group]